Rheumatoid arthritis: a time to capitalise on drug cost reductions - Health Service Journal

Rheumatoid arthritis: a time to capitalise on drug cost reductions  Health Service Journal

Pfizer commissioned this article written by Dr James Galloway (JG). No honorarium was paid to JG but Pfizer funded the article's publication and has final ...



Comments

Popular posts from this blog

Epstein-Barr virus and autoimmune diseases

Chronic Lyme arthritis: A mystery solved?

Fibromyalgia — Latest Stories — Pain News Network